scPharmaceuticals Inc. (SCPH) Interest Expense USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
scPharmaceuticals Inc. quarterly/annual Interest Expense history and growth rate from 2017 to 2024.
  • scPharmaceuticals Inc. Interest Expense for the quarter ending March 31, 2024 was $2.1 M, a 7.14% increase year-over-year.
  • scPharmaceuticals Inc. Interest Expense for the twelve months ending March 31, 2024 was $8.26 M, a 74.1% increase year-over-year.
  • scPharmaceuticals Inc. annual Interest Expense for 2023 was $8.12 M, a 146% increase from 2022.
  • scPharmaceuticals Inc. annual Interest Expense for 2022 was $3.3 M, a 28.2% increase from 2021.
  • scPharmaceuticals Inc. annual Interest Expense for 2021 was $2.58 M, a 0.46% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $8.26 M $2.1 M +$140 K +7.14% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $8.12 M $2.09 M +$132 K +6.74% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $7.99 M $2.06 M +$1.68 M +446% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $6.31 M $2.01 M +$1.56 M +350% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $4.75 M $1.96 M +$1.44 M +279% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $3.3 M $1.96 M +$1.34 M +216% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $1.96 M $377 K -$290 K -43.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $2.25 M $447 K -$204 K -31.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $2.46 M $518 K -$118 K -18.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $2.58 M $621 K -$36 K -5.48% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $2.61 M $667 K +$12 K +1.83% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $2.6 M $651 K +$12 K +1.88% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $2.59 M $636 K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $2.59 M $657 K +$11 K +1.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 $2.58 M $655 K +$257 K +64.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $2.32 M $639 K +$270 K +73.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $2.05 M $636 K +$282 K +79.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $1.77 M $646 K +$275 K +74.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-23
Q3 2019 $1.49 M $398 K +$38 K +10.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $1.45 M $369 K +$10 K +2.79% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $1.44 M $354 K +$12 K +3.51% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $1.43 M $371 K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-24
Q3 2018 $360 K +$31 K +9.42% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $359 K +$227 K +172% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $342 K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q3 2017 $329 K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $132 K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.